Patient guide · Mounjaro for Diabetes
Mounjaro for Diabetes
A patient-written guide to tirzepatide for Type 2 Diabetes — adapted from the Mounjaro for Diabetes Facebook group's FAQ, co-authored by Gwynne Sullivan, Jeaneth Stephani, and Amy Nowacoski.
About this guide
This guide turns a years-long body of patient research and lived experience into plain-language answers, with citations. Authors are not medical professionals — every page tells you the same thing: talk to your doctor. What we add is context, sources, and the lived-experience nuance that doesn't fit in a clinical handout.
What is Mounjaro?
What tirzepatide is, why it was developed, and how it activates the GLP-1 and GIP receptors to regulate blood sugar and appetite.
10 questions →
Blood sugar & A1C
How Mounjaro affects A1C, fasting glucose, post-meal spikes, insulin resistance, and the question of T2D remission.
14 questions →
Weight loss
How much weight people lose, why it can feel slow when you're diabetic, taste changes, hunger return, and weight regain after stopping.
14 questions →
Dosing & titration
How to inject, what titrating up means, when (and whether) to escalate doses, and how long the 2.5 mg starter dose can last.
5 questions →
Side effects
Nausea, diarrhea, constipation, bloating, reflux — what's normal, when it fades, and patient-tested tips for getting through it.
9 questions →
Access & coverage
The manufacturer coupon, telehealth options, off-label prescribing, compounded versions, insurance coverage, and Medicare/Medicaid status.
7 questions →
Comorbidities & special topics
PCOS, NASH, kidney health, eyesight, the brain, the gut biome, fertility, cholesterol, inflammation — adjacent conditions tirzepatide may affect.
12 questions →
Drug comparisons
Mounjaro vs Trulicity, Mounjaro vs Ozempic/WeGovy, and the next-generation incretin drugs in the development pipeline.
4 questions →